A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

Clinical trial NCT03136237 · COMPLETED

Trial details

NCT number: NCT03136237
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2017-02-17
Primary completion: 2017-08-15
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.